Analyst Price Targets — AMRN
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| January 6, 2023 5:23 am | — | Jefferies | $3.00 | $1.26 | Benzinga | Jefferies Upgrades Amarin Corp to Buy, Raises Price Target to $3 |
| May 24, 2022 7:21 am | — | Goldman Sachs | $1.50 | $1.41 | Benzinga | Goldman Sachs Maintains Sell on Amarin Corp, Lowers Price Target to $1.5 |
| May 5, 2022 12:00 am | Carl Byrnes | Northland Securities | $2.00 | $1.56 | TipRanks Contributor | Amarin Nosedives on Disappointing Quarterly Results |
Latest News for AMRN
DUBLIN and BRIDGEWATER, N.J., April 15, 2026 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN), a company advancing the science of cardiovascular therapeutics worldwide, today announced that it will report first quarter 2026 financial results and conduct a conference call on Wednesday, April 29, 2026. The Company will issue a press release detailing its first quarter 2026 financial results in the pre-market…
Amarin has one drug, and it has lost key patent protections. The company is cutting costs in an effort to generate positive cash flow.
Amarin shares surge 37.7% in a year as restructuring, cost cuts and expanding Vazkepa partnerships for international growth fuel optimism.
Amarin's results depend on a single medicine that is already facing generic competition. By contrast, Novartis has a deep lineup, plenty of growth products, and a solid dividend program.
Amarin (NASDAQ: AMRN) executives told investors that 2025 marked a "substantial achievement" year as the company advanced a strategic pivot toward a more partnered international commercial model and executed a global restructuring aimed at lowering its operating expense base. On the company's fourth-quarter and full-year 2025 earnings call, management highlighted a new long-term agreement with Recordati
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for AMRN.
U.S. House Trading
No House trades found for AMRN.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.